REGENXBIO Inc.

RGNX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2020

Total Assets: $708.2M

Liabilities Breakdown FY2020

Total Liabilities: $330.4M